Matrix metalloproteinase 9 variation in erosive oral lichen planus before and after treatment

An investigation on matirx metalloproteinase 9 variation in erosive oral lichen planus before and after treatment by triamcinolone mouthwash

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016071728963N1

Enrollment

Registered

2016-11-11

Start date

2016-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

erosive oral lichen planus. Other lichen planus

Interventions

Treatment will be done by triamcinolone mouthwash( that is formulated 1 cc triamcinolone vial in 19 cc distilled water) for 4 times daily after meals..

Treatment - Drugs

Treatment will be done by triamcinolone mouthwash( that is formulated 1 cc triamcinolone vial in 19 cc distilled water) for 4 times daily after meals.

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with erosive oral lichen planus with clinical and pathological confirmation whom need treatment. Exclusion criteria: Cutaneous lichen planus; Drug lichenoid reaction; Contact lichenoid reaction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Matrix metalloproteinase 9. Timepoint: before and after treatment. Method of measurement: ELIASA technique.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Jamile Bigom Taheri

Shahid Beheshti dental college

jm_taheri2006@yahoo.com+98 21 2217 5350

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026